Back to Authors

Yamaguchi, Yu

0000-0003-0098-281X

A5061745258 | I188891513

Mayo Clinic

Sanford Burnham Prebys Medical Discovery Institute

Citations 1

Neuronal heparan sulfates promote amyloid pathology by modulating brain amyloid-β clearance and aggregation in Alzheimer’s disease

Science Translational Medicine | March 30, 2016 | Volume: 8 | Issue: 332 | Pages: No page available

10.1126/scitranslmed.aad3650 | PMID 27030596

Deleting neuronal heparan sulfates in a mouse model of Alzheimer’s disease results in faster Aβ clearance, reduced Aβ aggregation, and less amyloid pathology.